Cancer Commons founder Marty Tenenbaum, PhD, will speak about Cancer Commons at the Stanford Medicine X | CHANGE conference this Sunday, September 22 at 9:15 am. The conference is a “premier gathering of patients, providers, researchers, designers and technologists who are leading disruptive CHANGE in health care.” Marty, who founded Cancer Commons after his own cancer journey, will discuss some of the major problems he’s working to fix: Clinical oncology… Read more »
H8Cancer Founder and CEO Simeon Jaggernauth, DO, FACP
On Saturday, Sandy Noack, Cancer Commons development officer and patient concierge, joined nearly 2,000 guests to “rock for a cure” at Tomstock 2019. This annual, invitation-only event raises funds for the H8 Cancer Foundation, a major supporter of our mission and work. Although our founder Marty Tenenbaum was unable to attend, he delivered this heartfelt message, read to the crowd by Tomstock host Carman Duvall:… Read more »
This Saturday, Cancer Commons will join an expected 2000 guests to “rock for a cure” at Tomstock, a day-long music festival that supports people who have been touched by cancer and fuels research needed to improve cancer care. Now in its 6th year, Tomstock is a private, invitation-only benefit event for the H8 Cancer Foundation, a major funder of our mission and work. Last year, Tomstock 5 raised… Read more »
From a new piece by InMenlo: “Marty Tenenbaum walked out of the Menlo Medical Clinic dazed. He’d just been diagnosed with metastatic melanoma and given just months to live. “That was in 1998. In his search for medical treatment options, the doctors he consulted had different advice, but all agreed his condition was dire.” Read the full article here.
Cancer Commons is teaming up with eight other healthcare innovators to form the Oncology Clinical Trial Information Commons (OCTIC), a shared platform that will improve cancer patients’ access to information about clinical trials. Organized by the Biden Cancer Initiative, this collaboration also includes BreastCancerTrials.org, Ciitizen, EmergingMed, GenomOncology, Genospace/Sarah Cannon Research Institute, IBM Watson Health, Massive Bio, and Syapse. Together, we’ll build the first release of OCTIC, which will unite each collaborator’s current technologies… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will deliver a Keynote Chat at Cancer Advance Boston on Wednesday, April 24 at 2:40pm. This annual gathering is “an invitation-only, off-the-record forum that brings together the past, present and future leaders to network and share expertise in cancer therapeutics.” Marty, who founded Cancer Commons after dealing with his own cancer diagnosis, will discuss some of the major problems he’s working to fix: “Clinical oncology… Read more »
Masako Yokota (center) and David Stein (right) will perform works by composer George Gershwin (left). Gershwin photo from George Grantham Bain collection, Library of Congress
We warmly invite everyone in the Cancer Commons community to an afternoon of lovely and lively music on Sunday June 9, in Los Altos, CA. Organized by our very own Masako Yokota, a cancer survivor and classically trained vocalist, the concert will feature a selection of tunes by renowned American composer George Gershwin. Ms. Yokota will be joined by local pianist and accompanist David Stein;… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak at the 26th International Molecular Medicine Tri-Conference in San Francisco on March 12. At 8:15 am, he will moderate an expert panel discussion on “Data Science Enabling Personalized Medicine“: “Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak at the upcoming Bridging Clinical Research & Clinical Health Care Collaborative at the National Academy of Sciences in Washington, DC, on March 4 at 5:00 pm. Marty, who founded Cancer Commons after his own battle with melanoma, will facilitate an expert panel discussion on “Reinventing Clinical Research and Cancer Care.” That same day, he will also lead a lunchtime discussion… Read more »
I always say that Emma was an angel that appeared in my life. Rapidly, I saw that her advice was professional and that her insights matched the latest publications, so I have developed very strong trust in her… Moreover, what I appreciate the most about Emma is her human goodness and empathy. I have never felt I was just a case for her. She… Read more »
